Two decades of innovation reveal mixed findings for quality, cost, and utilization—and unclear ways to resolve. The results are in on the impact of value-based payments (VBP) and once again, they're ...

What’s the best way to improve commercial performance? For biopharma companies, according to a report from Accenture, the answer is investment and innovation. In a five-year study of 15 drugmakers, ...

Developing alternative payment models for commercial populations in specialties such as oncology is rife with practical challenges. Leading payers and practices share lessons to date. Many payers and ...

The pharmaceutical industry is facing unprecedented disruption, necessitating a fundamental shift in how leaders perceive and respond to market dynamics. Traditional commercial models are no longer ...

Fusion energy, long the holy grail of clean energy enthusiasts, has endured decades of research, often with considerable financial strain. While privately funded tech tycoons and governments alike are ...

Biopharmaceutical companies are looking for go-to-market approaches that go beyond customer expectations. Starting with a revolutionized technology platform allows these organizations to create value ...

The pharmaceutical industry is undergoing a commercial evolution. Traditional sales and marketing tactics — such as the classic in-person sales rep model — have declined, straining under the pressure ...

Meta Platforms Inc. is planning to release a commercial version of its artificial intelligence model designed for commercial use, according to a report today from the Financial Times. Meta released ...